-Wall Street Journal Report
Related Posts
Johnson & Johnson Reaches $230M Settlement With New York State To End Sale Of Opioids Nationwide
On Saturday, Johnson & Johnson (NYSE: JNJ) said it would end the manufacture and sale of opioids nationwide in a $230 million settlement with the New York state,
Credit Suisse Maintains Neutral on Bed Bath & Beyond, Lowers Price Target to $23
Credit Suisse analyst Lavesh Hemnani maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Neutral and lowers the price target from $30 to $23.
Goldman Sachs Downgrades Timken to Neutral, Lowers Price Target to $73
Goldman Sachs analyst Joe Ritchie downgrades Timken (NYSE:TKR) from Buy to Neutral and lowers the price target from $84 to $73.